O-1602
Product Specifications
CAS Number
317321-41-8
Target
Calcium Channel|||Cannabinoid Receptor
Related Pathways
GPCR/G Protein|||Metabolism|||Membrane transporter/Ion channel
Purity
0.9985
Bioactivity
O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.O-1602 promotes hepatic steatosis through GPR55 and PI3 kinase / Akt / SREBP-1c signalling in mice.O-1602 induces, in a GPR3-independent manner, in Hep55B cells with elevated intracellular calcium.
Smiles
CC1=C(C(O)=CC(O)=C1)[C@H]2[C@H](C(C)=C)CCC(C)=C2
Molecular Formula
C17H22O2
Molecular Weight
258.36
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1169097-01 0.02 mg (E-Coli)
Recombinant Shewanella sediminis Lipoyl synthase (lipA)
Ask
View Details MBS1169097-02 0.02 mg (Yeast)
Recombinant Shewanella sediminis Lipoyl synthase (lipA)
Ask
View Details 
MBS1169097-03 0.1 mg (E-Coli)
Recombinant Shewanella sediminis Lipoyl synthase (lipA)
Ask
View Details MBS1169097-04 0.1 mg (Yeast)
Recombinant Shewanella sediminis Lipoyl synthase (lipA)
Ask
View Details